Concepedia

Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin®) eye drops against corneal neovascularization

Y. Koenig, Felix Bock, Folkert K. Horn, Friedrich E. Kruse, Katja Straub, Claus Cursiefen

Graefe s Archive for Clinical and Experimental Ophthalmology · 2009 · 178 citations · 15 references

DOI

Concepts

References

15

Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders

Lloyd Paul Aiello, Robert L. Avery, Paul G. Arrigg et al. · New England Journal of Medicine · 1994 · 3.8K citations · Full text

, , +15

Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration

Robert L. Avery, Dante J. Pieramici, Melvin Rabena et al. · Ophthalmology · 2006 · 1.1K citations

, , +14

Inhibition of Hemangiogenesis and Lymphangiogenesis<i>after</i>Normal-Risk Corneal Transplantation by Neutralizing VEGF Promotes Graft Survival

Claus Cursiefen, Jingtai Cao, Lu Chen et al. · Investigative Ophthalmology & Visual Science · 2004 · 332 citations · Full text

, , +16

Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.

Wolfgang Philipp, L. Speicher, Christian Humpel · PubMed · 2000 · 322 citations

, , +17

Bevacizumab as a Potent Inhibitor of Inflammatory Corneal Angiogenesis and Lymphangiogenesis

Felix Bock, Jasmine Onderka, Tina Dietrich-Ntoukas et al. · Investigative Ophthalmology & Visual Science · 2007 · 320 citations · Full text

, , +16